Group One Trading, L.P. Aldeyra Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.2 Billion
Q1 2025

A detailed history of Group One Trading, L.P. transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 164,411 shares of ALDX stock, worth $424,180. This represents 0.04% of its overall portfolio holdings.

Number of Shares

164,411

Previous 204,151 19.47%

Holding current value

$424,180

Previous $1.02 Million 7.17%

% of portfolio

0.04%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$4.7 - $6.98 $186,778 - $277,385	-39,740 Reduced 19.47%	164,411 $945,000
Q4 2024 Feb 14, 2025	BUY	$4.21 - $5.9 $735,566 - $1.03 Million	174,719 Added 593.64%	204,151 $1.02 Million
Q3 2024 Nov 14, 2024	BUY	$3.19 - $6.32 $87,999 - $174,343	27,586 Added 1494.37%	29,432 $158,000
Q2 2024 Aug 14, 2024	SELL	$3.25 - $4.72 $13,650 - $19,824	-4,200 Reduced 69.47%	1,846 $6,000
Q1 2024 May 10, 2024	SELL	$2.77 - $4.22 $19,276 - $29,366	-6,959 Reduced 53.51%	6,046 $19,000
Q4 2023 Feb 14, 2024	SELL	$1.47 - $6.06 $77,235 - $318,398	-52,541 Reduced 80.16%	13,005 $45,000
Q3 2023 Nov 09, 2023	BUY	$6.11 - $8.16 $400,486 - $534,855	65,546 New	65,546 $437,000
Q1 2023 May 12, 2023	BUY	$5.77 - $9.93 $497,904 - $856,879	86,292 Added 590.35%	100,909 $1 Million
Q4 2022 Feb 09, 2023	SELL	$5.08 - $7.09 $57,383 - $80,088	-11,296 Reduced 43.59%	14,617 $101,000
Q3 2022 Nov 09, 2022	BUY	$3.8 - $7.74 $9,868 - $20,100	2,597 Added 11.14%	25,913 $138,000
Q2 2022 Aug 11, 2022	SELL	$2.43 - $4.85 $120,897 - $241,297	-49,752 Reduced 68.09%	23,316 $93,000
Q1 2022 May 12, 2022	SELL	$3.25 - $5.17 $18,850 - $29,986	-5,800 Reduced 7.35%	73,068 $325,000
Q4 2021 Feb 11, 2022	SELL	$3.5 - $9.63 $8,585 - $23,622	-2,453 Reduced 3.02%	78,868 $315,000
Q3 2021 Nov 12, 2021	BUY	$7.94 - $11.31 $645,688 - $919,740	81,321 New	81,321 $714,000
Q2 2021 Aug 10, 2021	SELL	$10.44 - $14.85 $632,173 - $899,212	-60,553 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$6.53 - $14.42 $395,411 - $873,174	60,553 New	60,553 $719,000
Q4 2020 Feb 10, 2021	SELL	$6.31 - $8.13 $152,462 - $196,437	-24,162 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$4.0 - $7.53 $57,660 - $108,544	14,415 Added 147.89%	24,162 $179,000
Q2 2020 Aug 13, 2020	BUY	$1.97 - $5.05 $5,210 - $13,357	2,645 Added 37.24%	9,747 $41,000
Q1 2020 May 13, 2020	SELL	$1.62 - $6.4 $6,598 - $26,067	-4,073 Reduced 36.45%	7,102 $18,000
Q4 2019 Feb 10, 2020	BUY	$4.73 - $7.98 $23,233 - $39,197	4,912 Added 78.43%	11,175 $65,000
Q3 2019 Nov 12, 2019	SELL	$4.41 - $6.12 $40,572 - $56,304	-9,200 Reduced 59.5%	6,263 $33,000
Q2 2019 Aug 09, 2019	SELL	$6.0 - $9.0 $72,552 - $108,828	-12,092 Reduced 43.88%	15,463 $93,000
Q1 2019 May 13, 2019	BUY	$7.14 - $9.85 $196,742 - $271,416	27,555 New	27,555 $249,000
Q4 2018 Feb 06, 2019	SELL	$7.26 - $13.29 $3,317 - $6,073	-457 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$6.8 - $14.35 $1,652 - $3,487	-243 Reduced 34.71%	457 $6,000
Q2 2018 Aug 14, 2018	BUY	$6.95 - $9.18 $4,865 - $6,426	700 New	700 $6,000

Others Institutions Holding ALDX

# of Institutions

139

Shares Held

38.6M

Call Options Held

620K

Put Options Held

435K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $150M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Aldeyra Therapeutics, Inc. Transaction History